Caxton Corp
10% Owner

Caxton Corp insider trades: Strongbridge Biopharma (SBBP) stock purchases

10% Owner, Strongbridge Biopharma Last trade Sep 18, 2020 19 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2017
5
Companies
last trade 2020

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Caxton Corp reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 18, 2020SBBP↑ Buy$3.3M
Nov 21, 2019MTEM↑ Buy$3.8M
Dec 27, 2018SBBP↑ Buy$197K
Dec 26, 2018MTEM↑ Buy$86K
Dec 21, 2018SBBP↑ Buy$943K
Sep 25, 2018MTEM↑ Buy$3.0M
Aug 8, 2018SBBP↑ Buy$1.8M
Jul 30, 2018SBBP↑ Buy$326K
Jul 27, 2018SBBP↑ Buy$1.9M
Jul 23, 2018SBBP↑ Buy$276K
Jul 16, 2018SBBP↑ Buy$56K
Jul 20, 2017KALA↑ Buy$3.2M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Caxton Corp's insider trades

Caxton Corp is a 10% owner of Strongbridge Biopharma (SBBP). Since Jul 20, 2017, it has reported 12 open-market purchases worth $18.9M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Its filings also include other transactions (5 filings), gifts (1 filing), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SBBP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.